Reasons for choosing our testing services
ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.
Internationally recognized authority
Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.
Global service capability
Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.
Professional experimental methods
Adopt standard experimental methods to ensure accurate and reliable data.
Specialized Analytical Services for Guinea Pig Chymase: Activity, Inhibition, and Immunodetection
Guinea pig chymase (GPC) is a serine protease predominantly found in mast cell secretory granules, playing a pivotal role in the pathophysiology of allergic inflammation, asthma, and cardiovascular remodeling. As a highly specific and sensitive biomarker in various disease models, the accurate detection and characterization of guinea pig chymase activity are essential for preclinical drug development, mechanistic studies of inflammation, and the evaluation of novel protease inhibitors. Our advanced analytical platform provides comprehensive services for the precise quantification, kinetic profiling, and inhibition analysis of guinea pig chymase, delivering data of exceptional quality and reproducibility to support your research and development programs.
Understanding the Client's Need for Guinea Pig Chymase Detection
Clients seeking guinea pig chymase detection services are typically driven by one or more of the following objectives: (i) evaluating the potency and selectivity of novel small-molecule chymase inhibitors in a relevant preclinical model; (ii) quantifying chymase activity in tissue homogenates, bronchoalveolar lavage fluid (BALF), or cell culture supernatants from guinea pig models of allergic airway disease; (iii) assessing the role of chymase in angiotensin II generation, extracellular matrix remodeling, or mast cell degranulation; (iv) validating the purity and activity of recombinant guinea pig chymase preparations for use as reference standards or in screening assays; and (v) supporting regulatory submissions for new therapeutic candidates targeting chymase-mediated pathways. Our service is designed to address these diverse needs with scientific rigor and operational efficiency, providing clients with high-quality, actionable data.
Advanced Analytical Platform for Comprehensive GPC Profiling
Our analytical platform is built upon a validated, multi-parameter approach to guinea pig chymase characterization, integrating three interconnected modules: the Activity and Kinetics Module, the Immunodetection Module, and the Inhibitor Screening Module. The Activity and Kinetics Module employs a highly sensitive continuous fluorometric assay using the specific chymase substrate Suc-Ala-Ala-Pro-Phe-AMC, which is cleaved to release the fluorescent 7-amino-4-methylcoumarin (AMC) product. We meticulously optimize assay conditions for guinea pig chymase, including pH, ionic strength, and temperature, to ensure maximal activity and specificity. Kinetic parameters, including Michaelis-Menten constants (Km, Vmax, and kcat), are determined with high precision, enabling a thorough understanding of enzyme-substrate interactions and the impact of potential modulators. Our assay achieves a limit of detection (LOD) as low as 0.1 ng/mL for purified GPC and inter-assay precision within ±3% RSD.
The Immunodetection Module provides qualitative and quantitative analysis of guinea pig chymase protein expression using a validated sandwich ELISA. Our assay utilizes highly specific monoclonal antibodies against guinea pig chymase, ensuring minimal cross-reactivity with other chymases or mast cell proteases. This module offers sensitivity down to 0.05 ng/mL in complex matrices such as plasma, BALF, and tissue homogenates, with linearity over a 10,000-fold dynamic range. Additionally, we offer western blotting with enhanced chemiluminescence detection for confirmatory analysis and for studying chymase in its native or processed forms.
Unmatched Analytical Sensitivity, Specificity, and Throughput
Our guinea pig chymase detection services are distinguished by their superior analytical performance and adaptability. The fluorogenic activity assay is designed to differentiate chymase activity from other serine proteases (such as tryptase or cathepsin G) through the use of selective substrates and inhibitors, providing a reliable measure of chymase-specific activity in complex biological samples. We have also developed a high-throughput format using 384-well microplates, allowing the screening of up to 1,000 compounds or samples per day without compromising data quality. This is particularly valuable for early-stage drug discovery campaigns where rapid hit identification and lead optimization are critical.
Distinctive Advantages of Our Guinea Pig Chymase Detection Service
Our service provides several unique benefits that directly address client challenges and accelerate research timelines. First, we offer customized assay development for non-standard matrices or specific research questions, including the analysis of chymase activity in subcellular fractions, exosomes, or paraffin-embedded tissues (following protein extraction). Second, our comprehensive data interpretation package includes robust statistical analysis, detailed kinetic modeling, and graphical representation of results, enabling clients to rapidly translate analytical findings into biological insights. Third, we provide full regulatory support, with all methods validated according to ICH Q2(R1) guidelines, and we supply detailed validation reports and certificates of analysis for each sample batch, ensuring compliance with preclinical and clinical data requirements. Fourth, our global logistics network ensures the safe and timely transport of biological samples under strictly controlled conditions (e.g., dry ice or liquid nitrogen), preserving analyte integrity from collection to analysis. Fifth, we maintain an extensive in-house reference standard library of guinea pig chymase inhibitors, substrates, and calibration materials, sourced from both commercial and custom-synthesized batches, guaranteeing reagent reliability and lot-to-lot consistency.
Furthermore, our team comprises PhD-level scientists with specialized expertise in mast cell biology, protease enzymology, and preclinical pharmacology. We offer dedicated consultation on experimental design, result interpretation, and the translation of findings to downstream applications, whether for academic publication, patent filings, or Investigational New Drug (IND) submissions. Our commitment to scientific excellence and client partnership ensures that you receive not just data, but actionable intelligence to advance your guinea pig chymase research and therapeutic programs.